| Authors: |
Burrows H; Yale School of Public Health, Yale University, New Haven, CT, USA. Electronic address: holly.burrows@princeton.edu., Antillón M; Yale School of Public Health, Yale University, New Haven, CT, USA; Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland., Gauld JS; Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, WA, USA., Kim JH; Public Health, Access, and Vaccine Epidemiology (PAVE) Unit, International Vaccine Institute, Seoul, Republic of Korea., Mogasale V; Policy and Economic Research Department, International Vaccine Institute, Seoul 08826, Republic of Korea., Ryckman T; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA., Lo NC; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Pitzer VE; Yale School of Public Health, Yale University, New Haven, CT, USA. Electronic address: virginia.pitzer@yale.edu. |
